Making Trial Data Count Twitter Q&A round-up
Latest News
Overall survival results from ICON6 recurrent ovarian cancer trial
Overall survival results from ICON6 recurrent ovarian cancer trial
Making Trial Data Count Twitter Q&A
Making Trial Data Count Twitter Q&A
Upfront abiraterone improves survival for men with prostate cancer
Upfront abiraterone improves survival for men with prostate cancer
Did you miss our #smallpopulations Twitter Q&A? Catch up here
Did you miss our #smallpopulations Twitter Q&A? Catch up here